{"id":339503,"date":"2025-08-12T21:50:18","date_gmt":"2025-08-12T21:50:18","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/339503\/"},"modified":"2025-08-12T21:50:18","modified_gmt":"2025-08-12T21:50:18","slug":"fda-updates-opioid-labels-to-emphasize-long-term-risks-the-presidential-prayer-team","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/339503\/","title":{"rendered":"FDA Updates Opioid Labels to Emphasize Long-Term Risks \u2013 The Presidential Prayer Team"},"content":{"rendered":"<p><img width=\"730\" height=\"438\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/08\/Rx-bottle-e1600188756784-730x438.jpeg\" class=\"attachment-wise-post-thumb size-wise-post-thumb wp-post-image\" alt=\"Rx bottle\" decoding=\"async\" loading=\"lazy\"  \/>\t\t\t<\/p>\n<p>New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose.<\/p>\n<p>The U.S. Food and Drug Administration (FDA) has mandated updated safety labels for all prescription opioid pain medications to more clearly reflect the risks associated with long-term use. The decision follows a May advisory committee meeting that reviewed studies showing increased dangers of misuse, dependence, and both fatal and non-fatal overdoses in patients using opioids over extended periods.\n<\/p>\n<p>The FDA\u2019s review concluded that existing labels lacked adequate warnings and failed to reflect the absence of well-controlled studies supporting long-term use. The new labels will include stronger warnings on addiction risks, dose-related harm, and the dangers of abruptly discontinuing medication, along with guidance for when long-acting opioids should be considered.\n<\/p>\n<p>\u201cThe death of almost one million Americans during the opioid epidemic has been one of the cardinal failures of the public health establishment,\u201d said FDA Commissioner Marty Makary. \u201cThis long-overdue labeling change is only part of what needs to be done \u2014 we also need to modernize our approval processes and post-market monitoring so that nothing like this ever happens again.\u201d\n<\/p>\n<p>In addition to labeling changes, the FDA is now requiring a new clinical trial to more rigorously study the long-term effects of opioids. Drug manufacturers must submit the updated labels within 30 days.\n<\/p>\n<p><strong>As the Lord Leads, Pray with Us\u2026<\/strong><\/p>\n<ul>\n<li>For Secretary Kennedy to seek the Lord as he oversees the review of federal health regulations.<\/li>\n<li>For Commissioner Makary to receive God\u2019s guidance as he heads the Food and Drug Administration.<\/li>\n<\/ul>\n<p class=\"has-text-align-right has-cyan-bluish-gray-color has-text-color\"> <strong>Sources:<\/strong> Department of Health and Human Services\n<\/p>\n<p>RECENT PRAYER UPDATES<\/p>\n","protected":false},"excerpt":{"rendered":"New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose. The&hellip;\n","protected":false},"author":2,"featured_media":339504,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,4326,16,15],"class_list":{"0":"post-339503","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115018008397519759","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/339503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=339503"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/339503\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/339504"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=339503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=339503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=339503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}